Article
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.
Translational psychiatry - 16 Feb 2016
Morgan C J A, Freeman T P, Powell J, Curran H V
Abstract excerpt
Smoking cannabis daily doubles an individual's risk of developing a psychotic disorder, yet indicators of specific vulnerability have proved largely elusive. Genetic variation is one potential risk modifier. Single-nucleotide polymorphisms in the AKT1 and catechol-O-methyltransferase (COMT) genes have been implicated in the interaction between cannabis, psychosis and cognition, but no studies have examined their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
